Abstract
Connexin (Cx) and pannexin (Panx) containing channels – gap junctions (GJs) and hemichannels (HCs) – are present in virtually all cells and tissues. Currently, the role of these channels under physiological conditions is well defined. However, their role in the immune response and pathological conditions has only recently been explored. Data from several laboratories demonstrates that infectious agents, including HIV, have evolved to take advantage of GJs and HCs to improve viral/bacterial replication, enhance inflammation, and help spread toxicity into neighboring areas. In the current review, we discuss the role of Cx and Panx containing channels in immune activation and the pathogenesis of several infectious diseases. This article is part of a Special Issue entitled: Gap Junction Proteins edited by Jean Claude Herve.
Keywords: Apoptosis, Reservoirs, NeuroAIDS, Anti-retroviral, Cure
1. Introduction
The innate immune response, a critical step in the defense against infectious agents, is composed of the epithelial and endothelial barriers, neutrophils, macrophages and monocytes, dendritic cells, granulocytes, natural killer cells and mast cells. Normally this type of immune response is transient and not specific to any given pathogen [1–4]. In contrast, the adaptive (or acquired) immune response, which is also composed of specialized cells, is highly specific to a particular pathogen and generate immunological memory. The generation of long lasting immunological memory requires cell-to-cell contact to maintain the specificity, proliferation, and differentiation of distinct cellular subsets [1–4]. Connexin (Cx) and pannexin (Panx) containing channels – gap junctions (GJ) and hemichannels (HC) – have been proposed to participate in these processes.
HCs are Cx hexamers formed by identical (homomeric) or different (heteromeric) Cx subunits. GJ channels are formed by the docking of two HCs positioned on the surface of two adjacent cells (Fig. 1A). GJs can be homotypic, i.e. formed by two identical HCs, or heterotypic, i.e. formed by different HCs [2,5–7]. The multiple potential combinations of different Cxs result in the formation of channels with different biophysical properties and permeability [8,9]. The large internal diameter of the pore of these channels is around 12 Å, allowing ions and intracellular messengers less than 1.2 kDa to diffuse between connected cells, including IP3, calcium, cyclic nucleotides, metabolites, toxic molecules, neurotransmitters, viral peptides, antigens, and electrical signals [2,5–7]. Non-docking HCs can open on the surface of the cells enabling the release of signaling molecules into the extracellular space including ATP, PGE2, S1L and NAD+ (Fig. 1B).
Fig. 1.
Schematic representation of Cx channels: gap junctions (GJs) and hemichannels (HCs). a) Representation of GJ channel communication from cell 1 to cell 2. GJ enable intracellular molecules to diffuse between connected cells. Some of these signaling molecules are ATP, IP3, Ca2+, toxic molecules and antigens (second messengers are represented as green balls) diffuse through cell 1 to cell 2 to coordinate several physiological and pathological functions. b) Representation of HCs on the surface of cells. Upon opening of these channels, intracellular signaling molecules such as ATP, NAD+, ions and other small molecules (represented as blue balls) are released into extracellular media.
Panxs are a family of proteins similar to Cxs, which consists of three members: Panx-1, -2 and -3 [10]. Panxs are structurally and topologically similar to Cxs, although they share no sequence homology. Like Cxs, Panxs consist of a cytosolic N-terminal domain, four transmembrane domains with two extracellular loops and a cytosolic C-terminal domain [11,12]. Also like Cxs, Panx proteins form large pore channels located on the plasma membrane. Initially, it was speculated that Panx channels could form GJ channels between adjacent cells [13–15]. However, ultra-structural analysis by electron microscopy indicated that Panx-1 junctional areas do not appear as canonical GJs [12]. In support of this conclusion, asparagine residues found in the extracellular domains of Panxs are glycosylated and therefore make docking between two Panxs unlikely due to structural/sterical hindrance [11,12].
Panx-1 is ubiquitously expressed in many cell types, including those in the eye, thyroid, prostate, kidney, liver, immune system, and CNS [16]. Panx-2 is mainly expressed in the central nervous system (CNS) while Panx-3 is localized in the skin, osteoblasts, and chondrocytes [17,18]. While Panx channels remain in a closed state under physiological conditions, they open during pathological conditions such as membrane depolarization, increased intracellular Ca2+ signaling, changes in blood flow, airway defense, tumorigenesis, cellular differentiation, cell death and during activation of innate and adaptive immune responses [19–21]. Upon Panx channel opening, small signaling molecules including NAD+, PGE2, glutamate, and ATP are released into the extracellular space resulting in autocrine and paracrine stimulation [22–25].
Cxs and Panxs are present in all immune cells and related tissues. Cx43 is the most well studied Cx isoform in the immune system and is expressed by macrophages, neutrophils, lymphocytes and mast cells during hematopoiesis, differentiation, and inflammatory reactions [26, 27]. However, for a long time, the expression and function of GJs and HCs in the immune system were highly controversial. Initially, lack of reliable evidence was mostly related to the fast degradation of Cxs/ Panx proteins in activated immune cells. Only recently, most laboratories and publications agreed that in parenchymal cells, Cxs are negatively affected by inflammatory conditions [27,28]. However, during the last 10 years, it became evident that the regulation of these channels is different in immune cells: increased protein expression, channel formation and opening are detected during immune activation and inflammation to coordinate the innate and adaptive immune responses [26,27]. In this review, we will describe the Cx/Panx expression profiles of several types of immune cells and the role of these channels in the generation, amplification, and consolidation of the innate and adaptive immune responses. Briefly, Cxs and Panxs are expressed in different immune cells and play a key role during the innate immune response. Table 1 resumes the different stimulus who improves the expression of GJ or HC. Below we will discuss the role of GJ and HC in particular immune cells.
Table 1.
Brief summary of the expression of different of Connexins (Cxs) and Pannexins (Panxs), and their role in the innate immune response as GJs or HCs.
Cell type | Cx/Panx expression | Specific stimuli | Gap junction (GJ)/hemichannel (HC) | Ref. |
---|---|---|---|---|
Monocytes/macrophages | Cx43 | LPS, INF-γ, and TNF-α, oxidative stress, tissue-specific conditions present in atherosclerosis, communication with dendritic cells. | GJ | [38], [39], [47–50], [66–68] |
Cx32, Cx37, Cx43, Panx-1 | Sepsis, calcium, inflammatory diseases, HIV. | HC | [25], [70], [74], [80,81], [84] | |
Microglia | Cx29, Cx32, Cx36, Cx43, Cx45 | LPS, granulocyte-macrophage colony-stimulating factor, INF-γ, and TNF-α, injury border or penumbra, Staphylococcus aureus-derived peptidoglycan. | GJ | [36], [37], [57–59] |
Panx-1, Panx-2 | INF-γ, TNF-α, ATP, amyloid-β peptide, IL-1β | HC | [85–91] | |
Kupffer's cells | Cx43 | Proinflammatory agent (LPS and INF-γ) | GJ | [35] |
Mouse Macrophage cell line J774 | Cx43 | ATP | GJ | [40–43] |
Astrocytes | Cx43 | Quinine, metabolic inhibition | HC | [71,73] |
B lymphocyte | Cx43 | Chemokines | GJ | [44], [45] |
T-cells | Cx31.1, Cx32,Cx43, Cx45 and Cx46 | cAMP, INF-γ, TNF-α | GJ | [54], [92], [97–100], [103–105], [107] |
Cx43 | Cytokines, inflammation | HC | [93], [92] | |
Panx-1 | Pathological conditions, calcium, inflammation | HC | [93], [92], [112–116] | |
NK cells | Cx43 | LPS plus INF-γ, LPS plus TNF-α | GJ | [107], [62,110,111] |
Neutrophils | Cx40, Cx43 | LPS, INF-γ | GJ | [43] |
Panx-1 | Inhibition by hypertonic salines | HC | [120] | |
Granulocytes | Cx43 | Inflammation | GJ | [43] |
Eosinophils | Cx43 | Allergic inflammation | GJ | [118] |
Mast cells | Cx32, Cx43 | Inflammation | GJ | [123,124] |
Panx-2 | Inflammation | HC | [125] |
2. Expression of connexins and pannexins in immune cells
2.1. Role of GJs and HCs in monocyte/macrophage function
Monocytes are members of the mononuclear phagocyte system that originate in the bone marrow. They circulate for three days and then infiltrate different tissues to become resident macrophages [29,30]. Macrophages survive in tissues for weeks to years [31–34], and upon local activation or non-inflammatory surveillance, they migrate into damaged or apoptotic areas where they aggregate, present antigens, clear pathogens and help to eliminate damaged cells, thereby improving tissue recovery, renewal and coordinating the immune response during inflammatory conditions. Based on our publications and those of others, we propose that due to their physical proximity or aggregation, macrophages express Cxs and form GJs as well as open Cxs and Panx-1 HCs to enable an efficient local and systemic immune response.
In the 90s it was highly controversial and unclear whether macrophages expressed Cxs, formed GJs or HCs, or both. Ten years later, it was demonstrated that several immune cells including monocyte/macrophages, microglia, and Kupffer's cells express low levels of Cx43 under resting conditions, but upon specific stimulation Cx43 expression is induced [35–39]. Pioneering experiments using J774 cells, a mouse macrophage cell line, indicated that in response to ATP treatment macrophages can form a Cx43 containing pore that associated with purinergic receptor signaling [40–43]. This was one of the first indications that Cx43 containing channels (probably hemichannels) in concert with secreted ATP and purinergic receptors participate in the immune response. However, how immune cells activate Cx expression and functional communication is still poorly understood. Nevertheless, this data indicates that endothelial activation results in secretion of factors that induce Cx43 expression and promotes the formation of functional GJs in circulating cells. In agreement, in vivo, Cx43 expression has been detected in activated peritoneal macrophages; however, freshly isolated circulating monocytes (CD14+CD16− cells) were negative for Cx43 mRNA and protein. Furthermore, it was demonstrated that Cx43 expression was required for monocyte activation and adhesion to the endothelium and that increased expression of Cx43 in monocytes contributed to the enhanced release of metalloproteinases MMP-2 and MMP-9 to enable the transmigration of monocytes across the blood-brain barrier (BBB) [38]. In agreement, cell migration is critical for immune cell differentiation, tissue formation, and organ development [44]. Recent findings have shown that GJs, and specifically Cx43 containing channels, play an important role in these processes, impacting adhesion and cytoskeletal rearrangements, transendothelial migration and direct migration of B cells [45,46]. In this model, Cx43 containing channels were able to show membrane distribution, influenced by the F-actin cytoskeleton, rearrangement, and these channels were necessary for B cell motility, CXCL12-mediated (chemokine) and Rap1 (GTPase protein) activation, which regulate B cell migration [45].
Different stimulus can activate the generation and amplification of the immune response by GJs. It was found that the activation of PKC by PMA and increasing intracellular calcium using a calcium ionophore [38], lipopolysaccharide (LPS) or TNF-α in combination with IFN-γ, acts cooperatively to induce the expression of Cx43 and formation of functional GJ channels in monocytes/macrophages and microglia [38]. Other pathological conditions that induce expression of Cx43 in monocytes and macrophages are oxidative stress, general inflammation, and during the stabilization of atheromatous plaques [47]. For example, foam cells in the atherosclerotic lesions in the carotid artery were found to contain Cx43 mRNA [38,48]. Nevertheless, a definitive demonstration of functional macrophage-macrophage or macrophage-polymorphonuclear or epithelial cell GJ communication [49,50] in these types of lesions has been controversial [51,52]. One complicating factor is that expression of Cxs does not always translate into GJ communication. For example, in cancer, the expression of Cxs occasionally does not associate with functional GJ communication. Instead, Cxs serve as proto-oncogenes or “sinks” to accumulate proteins in the cytoplasm due to the multifunctional binding sites present in connexins [53,54]. Thus, a clear demonstration of functional coupling or HC opening is still required to prove diffusion of second messengers in these pathologies.
Microglia, one of the major components of the innate immune system in the brain and the primary immune cell in the central nervous system (CNS) [55], express Cx36 and Cx43 [36,37]. A higher expression of Cx36 was to found to be related to a possible mechanism for cellular hyperexcitability [56]. In vivo, our data demonstrated that upon a stab wound injury, microglia becomes activated and migrate to the damaged area. Upon microglia aggregation around the lesion, Cx43 expression and functional GJ channels were required for an effective immune response, clearing of debris and promoting partial regeneration [37,57]. Furthermore, after cryo-traumatic brain injury, activated microglia started expressing Cx29 and Cx32 in the injury border or penumbra regions [58]. The treatment of microglia with Staphylococcus aureus-derived peptidoglycan also resulted in efficient expression of Cx43 and functional inter-cellular communication [59]. Thus, cellular damage, inflammation and regeneration trigger expression of Cxs and functional GJ communication among aggregated microglia.
GJs also play an essential role in dendritic cell activation and the amplification of antigen presentation. Specifically, antigens can diffuse from the cell processing the antigen into GJ connected cells that have never been exposed to the pathogen. This process, called cross-presentation [60–65], enables coupled cells to share viral peptides (antigens) and trigger an effective cytotoxic T lymphocyte (CTL) response, even among cells never directly exposed to the pathogen [64]. Recently, it was demonstrated that oral tolerance could be established by sharing antigens via GJs between macrophages and dendritic cells [66]. We believe this mechanism of antigen signaling amplification explains a critical point mostly ignored in immunology: how cell-to-cell activation can result in a broad and systemic activation that cannot be explained by cell to cell contact with the antigen-presenting cell [67,68]. Currently, the challenge is understanding how this mechanism occurs in vivo.
In addition to GJs, Cxs also form HCs that upon opening enable intra-cellular metabolites to diffuse into the extracellular environment (Fig. 1B). Normally, Cx containing HC exist in a closed state. However, during cell volume changes in response to stress, apoptosis, and metabolic inhibition, these channels open [13,69–74]. In macrophages, the opening of HCs has been proposed to serve as a diffusion pathway for the release of intracellular messengers like ATP, NAD+ or Ca2+ into the extracellular space to mediate autocrine and paracrine communication [75]. In agreement, changes in extracellular ATP and intracellular calcium concentration can retro-regulate Cx HC opening and closing [75–79]. In inflammatory diseases, such as atherosclerosis, Cx37 HC (present in primary monocytes and macrophages) may control initiation of the development of atherosclerotic plaques by regulating monocyte adhesion to the endothelium [80]. The HIV-induced opening of Cx43 HC was also found to dysregulate the secretion of the dickkopf-1 protein [81]. The data indicate that HC containing Cxs or Panxs are critical in the generation, amplification, and resolution of inflammatory responses and contribute to the pathogenesis of several diseases.
Panxs only form HCs and are expressed in several immune cells including macrophages. During physiological conditions, the Panx-1 HCs remain in a closed state. However, upon Panx-1 HC opening, several in-tracellular factors such as ATP are released into the extracellular space resulting in activation of several purinergic and adenosine receptors [19,82]. The cross-talk between these channels and ATP/adenosine receptors initiates an intracellular signaling cascade which results in the rearrangement of the F-actin microfilament network in C6 cells [83]. The opening of Panx-1 HCs can also be induced by several chemokines in a transient manner to control directed chemotaxis in normal and pathological conditions, including migration of T cells into the spinal cord in an animal model of multiple sclerosis [25]. We showed that Panx-1 channels concentrate in the leading edge of the cell to control FAK activation and actin rearrangement [25]. Thus, the opening of Panx-1 HC is essential to control cell migration. Furthermore, only recently, our laboratory demonstrated that macrophages exposed to HIV release ATP via the opening of the Panx-1 HC, but not Cx43 HC, facilitating the autocrine activation of purinergic receptors, which plays a significant role in HIV entry and replication in human macrophages [25,84] (see model in Fig. 2). Reducing the synthesis or opening of Panx-1 channels resulted in the nearly complete blocking of HIV entry and replication [25,84]. Thus, these channels constitute an attractive potential therapeutic target to block or reduce HIV infection and replication.
Fig. 2.
Proposed mechanism of release ATP by opening Panx-1 HCs and subsequent activation of purinergic and adenosine signaling during the immune response. The release of ATP from intracellular space to extracellular media it is mediated by the opening of Panx-1 HCs on the surface of immune cells by stress-related stimuli. Upon opening ATP is released through the channel into the extracellular space to activate purinergic receptors (P2X and P2Y). In addition, secreted ATP is subjected to degradation mainly by ecto-ATPases resulting in the hydrolysis of ATP to ADP and ADP to AMP, which promotes the formation of adenosine and activation of adenosine receptors (P1).
Microglia under resting conditions express detectable levels of Panx-1 but not Panx-2 [85–87]. Activation of microglia with different pro-inflammatory agents including IFN-γ [88], amyloid-β peptide [89,90], TNF-α plus ATP [91], TNF-α plus IFN-γ [91], and TNF-α plus IL-1β [91] increases the expression as well as the opening of Panx-1 HCs. For example, treatment of microglia with amyloid-β increased Cx and Panx-1 expression as well as the opening of these channels to promote glutamate release, suggesting their participation in the pathogenesis of Alzheimer's disease [90]. In summary, GJs and HCs play key roles in monocyte/macrophage activation, differentiation, and transmigration as well as to coordinate their immune response.
2.2. The role of GJ and HC in T cell differentiation and immune response consolidation
T lymphocytes play a fundamental role in cell-mediated immunity. T-cells originate in the bone marrow, but their differentiation and maturation occurs in the thymus. Cxs and Panxs have been identified in several lymphoid tissues and cells, and are proposed to play a role in the generation, amplification, and consolidation of the immune response. For example, blocking Cx containing GJs and HCs by specific extracellular peptides disrupts immunoglobulin release and cytokine production by lymphocytes [92–94]. siRNA against Cx43 in bone marrow-derived dendritic cells leads to diminished T cell stimulation, suggesting that Cx43-mediated communication is essential to trigger efficient T cell proliferation [95]. Additionally, Th1 cells can downregulate Cx43 expression and communication in astrocytes via microglia activation [96], but the soluble factors controlling these changes in expression are unknown. In T cell differentiation, the expression of Cxs has been proposed to coordinate the exchange of nutrients, peptides, and second messengers including cyclic adenosine monophosphate (cAMP), an essential metabolite for T cell differentiation. High levels of cAMP can inhibit T cell function during the immune response, e.g. blunting CD4+ T cell activation, cell proliferation, and production of certain cytokines, such as IFN-γ and TNF-α [97–100]. Similarly, a high concentration of cAMP induces immunosuppressive effects and stimulates inflammation by promoting IL-17 production and Th17 cell expansion [101,102]. An increase in the intracellular concentration of cAMP also induces a higher expression of Cx31.1, Cx32, Cx43, Cx45, and Cx46 in T-cells, including Tregs [103–105], but the role of these Cxs in T cell differentiation is still under active investigation. Currently, the profile of Cx expression in T cell subpopulations, including Th1, Th2, Th17, Th0, and Tregs is unknown; however, it is likely that Cx containing channels participate in T cell differentiation and associated cytokine release. For instance, it has been reported that Cx43 HCs and GJs are required to sustain the proliferation and therefore clonal expansion of T cells to initiate an effective immune response [39].
The role of GJs and HCs in T cells has been investigated during pathological conditions including cancer. In human melanoma biopsies, it has been demonstrated that Cx43 is expressed between tumor and endothelial cells and between T-cells and cancer cells, indicative of GJ formation [54]. This study proposed that GJs between these cells regulate the formation of an immunological synapse among T lymphocytes and autologous melanoma cells [106]. In this model, the opening of Cx43 HCs has been associated with cytokine release by T-cells and regulation of Ca2+ oscillations among T cells. Furthermore, it has been reported that cell conjugates forming an immunological synapse may target melanoma cells [107]. A key cytokine involved in T cell activation is IFN-γ, and Cx43 in T cells is essential for its secretion; blocking Cx43 GJs substantially diminished IFN-γ secretion by primed T cells [107]. The secretion of these key cytokines is also essential to mediate proper T cell differentiation (surface markers) and to regulate all the downstream events of the immune response [28,108,109]. Thus, Cx43 GJs may contribute to sustained communication between T cell and antigen presenting cells, allowing optimal T cell activation [107].
In the context of cancer, Cx43 expression by NK cells plays a key role in mediating bidirectional and functional intercellular communication between NK cells and dendritic cells [107,110,111]. Moreover blocking Cx43 inhibited NK cell activation and reduced the influx of Ca+2 and cytokine release by T cells [107]. Using mimetic peptides for as a blocker of Cx43 reduced CD69 and CD25 (activation markers for T cells) expression and INF-γ release by dendritic stimulated NK cells [110]. Furthermore, cell-to-cell communication between dendritic cells is required for efficient immune activation including expression of costimulatory molecules such as CD80 and CD86, MHC class II and allostimulatory capacity [62].
Upon αβT-cell receptor engagement, T-cells use HCs to release ATP, resulting in subsequent activation of a purinergic receptor and cellular activation [112]. γδT cells purified from peripheral human blood rapidly release ATP upon in vitro stimulation with anti-CD3/CD28-coated beads or an intermediate of the isoprenoid synthesis pathway (IPP), resulting in cell activation. Pretreatment of γδT cells with Panx-1 blocker, carbenoxolone [(3β, 20β)-3-(3-carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid disodium] (CBX), or bafilomycin A (BFA) reverses the stimulation and induces an increase in extracellular ATP concentration, indicating that Panx-1 HC, Cx HC, and gap junctions contribute to the controlled release of ATP into the extracellular space [112]. Furthermore, T cell receptor (TCR) stimulation results in the influx of Ca2+, which is buffered by the mitochondria and promotes ATP synthesis. ATP released from activated T-cells through Panx-1 HCs was found to activate purinergic P2XR to sustain mitogen-activated protein kinase (MAPK) signaling [113]. In vivo administration of oATP, a purinergic receptor blocker reduces the onset of diabetes mediated by anti-islet TCR transgenic T cells and impairs the development of colitogenic T cells in inflammatory bowel disease [114–116]. In conclusion, HCs in concert with secreted ATP are not the only key to controlling the immune response and T-cell activation, but also play key roles in several diseases involving anergy, exhaustion and over-proliferation and activation often observed in several cancers and immune compromised individuals.
2.3. The role of GJs and HCs in granulocytes
Granulocytes (neutrophils, eosinophils, mast cells) are an essential part of the innate immune response. Cx and Panx containing channels are present in granulocytes to enhance inflammation and to promote cellular activation [117–119]. In particular, it has been shown that neutrophils aggregate and communicate with each other via GJ channels [43]. The demonstration of Cx expression in these cells was extremely difficult due to the high content of proteases that compromised the integrity of the Cxs proteins. Despite these problems, it has been shown that treatment with LPS or TNF-α induced the formation of aggregates of neutrophils that can communicate with endothelial cells via GJs [43] containing Cx43 and Cx40, but not Cx32 [43]. In addition to Cxs, granulocytes also express Panxs [43,120]. This area of research is still open, with a further examination required to understand the functions of Cx and Panx containing channels in neutrophils.
Eosinophils are a rich source of enzymes, chemokines, cytokines, and lipid mediators that participate in allergic inflammation [121,122]. Eosinophils from atopic individuals express Cx43 mRNA and the protein, but not Cx32, and Cx43 is localized not only in the cytoplasm but also to the plasma membrane [118]. The expression of Cx43 by eosinophils facilitates the transfer of second messengers to epithelial and endothelial cells. Cx43 also play a significant role in eosinophil transendothelial migration, enabling these cells to migrate to sites of inflammation [118]. Formation of GJs between eosinophils and tissue resident cells may provide another mechanism of interaction during inflammatory reactions, which could lead to limited and specific activation of communicating cells, as opposed to the broad activation obtained through the paracrine effects of released cytokines and chemokines [118].
Mast cells, also called mastocytes, express Cx43, Cx32 [123–125], and Panx-2 in myenteric and submucosal ganglia [126]. Cx43 and Cx32 expression have also been detected in murine bone marrow cultured mast cells and the mast cell line C57 [123]. Mast cells have important functions in the epidermis, wound healing, and diabetes, where Cx43 plays a key role [127]. However, whether these proteins form GJs or HCs in mast cells is still unknown.
3. Role of GJ and HC in the generation, amplification, and consolidation of inflammation
Inflammation is a first-line mechanism in the innate immune response to protect the body against pathogens and associated damage [128–130]. The purpose of inflammation is to eliminate the initial injury and to clear the damaged or dead cells from the tissue to enable tissue repair and regeneration [128]. The inflammatory process is a complex and multistep process, requiring the recruitment of immune cells, vasodilation, increased permeability, immune activation, apoptosis/necrosis, clearance of the pathogen/damage and regeneration [128]. The inflammatory response includes cell types such as fibroblasts, endothelial cells, and adipocytes, in addition to the typical circulating and resident leukocytes and mast cells, as well as the production of inflammatory cytokines and chemokines [128,131].
Changes in Cx expression and GJ communication in response to inflammation have been found in several cells and tissues. For example, in the presence of lipopolysaccharide (LPS), a potent inflammatory mediator, Cx expression decreases after inflammation in the heart [132–137], the liver [138,139], and the brain [140,141]. LPS treatment also reduces the expression of Cx40 and associated GJ communication in endothelial cells [142]. In pulmonary inflammatory diseases, expression of Cx37 and Cx40 decreases during lung inflammation [143]. In the brain, IL-1β decreases the expression of Cx43, inhibiting GJ coupling and conductance in human astrocytes [144]. In the liver, the cytokine IL-1β also reduces the expression of Cx32 and Cx43 [145,146]. These examples indicate that systemic inflammation decreases GJ expression and communication in parenchymal cells.
In contrast, in the liver, Kupffer's cells treated with LPS and IFN-γ show increased expression of Cx43 and functional GJ communication among aggregated liver macrophages [35,147]. Activation of Kupffer's cells in vivo and in vitro results in enhanced Cx43 expression and formation of GJ that regulate secretion of several cytokines and metalloproteases. LPS results in up-regulation of Cx40 expression in the aorta associated with reduced endothelium-dependent relaxation and omega-3 fatty acids supplementation decreases the expression of Cx40 in aortic tissue [148]. Thus, understanding the profiles of expression and function of these channels in inflammatory conditions could illuminate new therapeutic opportunities for these pathologies.
In the context of HCs, cell or tissue damage has been shown to cause the release of ATP via HC from damaged cells, resulting in P2 receptor-mediated purinergic signaling and the initiation of inflammation [25, 149]. Secreted ATP is one of the most potent inflammatory molecules and serves as a “find me signal” to coordinate the recruitment of monocytes, macrophages and dendritic cells into the damaged areas. As described previously, chemokines that bind CCR5 and CXCR4 transiently open Panx-1 channels, allowing the release of ATP to extracellular media, which also controls actin rearrangement for directed migration [150]. Thus, ATP and chemokines are highly integrated with HC function to support inflammation and regeneration.
Interestingly, Panx-1 HCs in inflammatory bowel diseases including colitis and Crohn's disease show a cell protective function, but the mechanism of this protection is unknown [151]. In the colon, there is a high density and broad cellular distribution of Panx-1, suggesting an important role of this protein in the gut. In an animal model of colitis, Panx-1 HC are required for P2X7 receptor-mediated enteric neuron cell death and associated intestinal inflammation [152,153]. Inhibition of Panx-1 HCs protects neurons and maintains proper control of the colonic muscles, preserving mobility [152]. Thus, Panx-1 HCs could be a novel therapeutic target for the treatment of dysfunction of inflammatory bowel diseases and possibly other gastrointestinal disorders with an inflammatory component.
4. The connection between HCs, ATP and purinergic receptors
As described above, HCs in concert with extracellular ATP are an important component of the inflammatory cascade, serving as a danger signal that causes activation of the inflammasome, immune cell infiltration, and tissue repair [154–157]. Also, GJs and HCs play a critical role in the resolution of pathogenic agents or spinal cord injury. For example, activation of P2X7 receptors by extracellular ATP released upon the opening of HCs results in enhanced intracellular bacterial killing and prevention of sepsis [74]. A similar mechanism has been described in macrophages infected with Bacillus anthracis [158]. A lethal B. anthracis toxin that blocks kinases p38, MAPK and AKT also results in the opening of Cx43 HCs, ATP release, and induction of macrophage death [158]. In the CNS, the opening of HCs has been described in astrocytes, neuronal precursors, neutrophils, and myocytes in response to different stimuli such as hypoxia, ischemia, as well as pathogen-associated molecular patterns (PAMPs) [159–166]. Experiments using Cx43 or Panx-1 knocked down astrocytes indicate that downregulation of Panx-1, but not Cx43, prevents the release of ATP from astrocytes [167]. In contrast, experiments using conditional Cx43 knockout demonstrate that reduction of Cx43 protein expression reduces animal recovery time and inflammation in response to spinal cord injury, suggesting a role for Cx43 HCs in inflammation and recovery [168].
Additionally, extracellular ATP participates in the activation of the inflammasome (NLPR3) [23,155,169]. Inflammasomes are large multiprotein complexes, leading to caspase-1-activated maturation of cytokines, including interleukin-1β (IL-1β) [170,171], by a P2X7 receptor-mediated mechanism [172]. The activation of P2X4 and P2X7 in response to ATP released by Panx-1 HCs has been related to induced ROS production and inflammasome activation in gingival epithelial cells [173]. The data further supports the involvement of Panx-1 HCs, purinergic receptors and extracellular ATP in inflammasome activation. Together, HCs, ATP, and purinergic receptors play a critical role during the inflammatory response and thus represent a promising target for new therapies.
Extracellular ATP also controls cellular and tissue defense/repair processes via signaling through P1, P2X, and P2Y purinergic receptors, with P2X7 signaling recently associated with tumor growth and metastasis [174]. For example, P2Y1 and P2Y2 receptors are involved in cell proliferation, P2X4 receptors are involved in differentiation (and are therefore anti-proliferative), and P2X7 receptors are involved in cell death [175–177]. Human melanomas express functional P2X7 receptors that mediate the apoptotic functions of ATP, whereas P2Y1 and P2Y2 receptor agonists cause a decrease and increase in cell numbers, respectively [175–177]. Thus, extracellular ATP can function as a prototypical danger signal that activates a potent immune response, but can also promote cancer progression [174]. Thus, cancer cells can use the ATP/ HC/purinergic system and autophagy to survive, metastasize and avoid the immune response.
5. The unexplored role of Cx and Panx containing channels in HIV infection, replication, and associated pathogenesis
Human immunodeficiency virus type-1 (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV infection is a major public health problem that is partially controlled by the use of antiretroviral agents [178–180]. HIV infects a variety of immune and non-immune cells, including CD4+ T cells, monocyte/macrophages, microglia, and astrocytes [84,181–183].
HIV entry into the CNS is an early event after infection [184], resulting in neurological dysfunction in a significant number of individuals. In 50–60% of the infected population, the neurological manifestation of HIV infection produces a number of debilitating clinical disorders collectively termed HIV-Associated Neurocognitive Disorders (HANDs) [185]. The HIV-induced CNS damage is dependent on HIV infection, but not on replication [186–188]. Our laboratory has proposed that GJ channels, chemical synapses and alternative mechanisms of cell-cell communication, such as HCs, amplify HIV-associated CNS damage (see diagram in Fig. 3A) [184]. Our results have shown that HIV-infected astrocytes and macrophages are protected from apoptosis, which possibly contributes to the persistence of HIV within the CNS [189–191]. Despite the low to undetectable HIV replication in these surviving cells, they are extremely well coupled by GJs and express functional Cx HCs on their surface. In the last couple of years, we demonstrated that GJ channels play a key role in transmitting and thereby amplifying toxic signals originating from HIV-infected astrocytes to uninfected astrocytes [190]. Furthermore, it was demonstrated that a few HIV-infected astrocytes (4.7 ± 2.8% in vitro and 8.2 ± 3.9% in vivo) compromise the BBB integrity by a mechanism involving activation of purinergic receptors, BK channels, and others [192]. We also demonstrated that GJs and HCs are essential to allow the spread of apoptotic signals into uninfected cells, including neurons, astrocytes and endothelial cells [193].
Fig. 3.
Cell to cell spread of apoptotic stimuli during HIV infection via GJs and HCs. a) GJ channels (in red), composed mainly of Cx43, remain expressed and open during HIV infection resulting in the transfer of toxic or apoptotic signal to uninfected cells resulting in apoptosis. Surprisingly, HIV-infected cells survive apoptosis generating viral reservoirs within the CNS. b) HCs (in blue), composed by Cx or Panx-1, allow the release of ATP into extracellular media and activate purinergic receptor in the targeted cell to facilitate HIV entry and infection but also ATP diffuse to surrounding uninfected cells to promote inflammation.
Recently we showed that HIV-tat (HIV-transactivator of the virus) enhances Cx43 expression in primary human astrocytes [184,194]. The data indicate that the presence of a single HIV protein, HIV-tat, expressed by an early HIV gene, increases Cx43 expression in astrocytes to maintain communication between the few HIV-infected cells and surrounding uninfected cells. This mechanism of promoting intercellular communication by a pathogen is unique and is not blocked by any anti-retroviral therapy. Our results show that a small number of HIV-infected astrocytes result in extensive alterations in glutamate metabolism and secretion of key chemokines (CCL2) involved in NeuroAIDS [193,195]. For instance, CCL2 alone can compromise the BBB, but if CCL2 reaches the circulation, it can also specifically recruit HIV-infected circulating cells into the CNS [196,197]. Thus, functional GJs in HIV-infected astrocytes contribute to the spread of toxic signals among cells and the recruitment of infected and inflammatory cells into the CNS.
The role of HCs in HIV infection was only recently described. HIV mostly infects immune cells by binding the viral envelope glycoprotein gp120 to the host extracellular proteins CD4, CCR5, and CXCR4, resulting in fusion of the viral envelope with the cell membrane [198]. No other host plasma proteins have been identified that participate directly in the process of viral entry [198]. However, we recently discovered that Panx-1 HCs are essential to support HIV entry into immune cells. Our data indicate that HIV binding to CD4 and CCR5 or CXCR4 results in an extended (up to 1 h) opening of Panx-1 HCs. This opening enables a local release of ATP that results first in P2X1 receptor activation, due to its high sensitivity to low amounts of ATP. P2X1 receptors are essential for HIV entry because they are necessary for actin rearrangement on the surface of the immune cells, which allows the virus to fuse with the plasma membrane. Later on, when the concentrations of ATP reach higher levels, P2X7 receptors become activated, but their role the HIV cell cycle is still under active investigation. Extracellular ATP is subjected to ectoATPases that produce ADP, AMP and later on adenosine. P2Y1 receptors also participate in HIV replication, but this receptor is mostly activated by ADP, and we are still working in the viral functions targeted by this receptor.
In addition, we found that Panx-1 HCs become transiently (in the range of second) open in response to chemokines binding to their receptors, CCR5 and CXCR4. Chemokine receptors normally activate upon binding of their endogenous ligands, chemokines, to regulate physiological and pathological cellular trafficking of particular cell populations into different tissues [199]. Thus, we propose that under normal conditions the transient opening of these HCs helps regulate cell trafficking. However, we also propose that several pathogens have adapted to take advantage of these channels to improve their infectivity and replication.
Recently it was demonstrated that HIV infection leads to the opening of Cx43 HCs in human astrocytes, and we found that this opening did not affect viral replication or bystander apoptosis. Instead, HIV-induced opening of Cx43 HCs led to dysregulated secretion of dickkopf-1 protein (DKK1), a soluble WNT pathway inhibitor [81]. DKK1 is an embryonic developmental protein involved in the anterior visceral endoderm development, resulting in heart, head and forelimb formation. However, HIV infection activates this embryonic program to spread toxicity and inflammation. Indeed, treatment of mixed cultures of neurons and astrocytes with DKK1 in the absence of HIV infection results in the collapse of neuronal processes [81]. These experiments demonstrate that HIV infection of astrocytes induces dysregulation of DKK1 by an HC-dependent mechanism, contributing to synaptic compromise observed in HIV-infected individuals. This data provides a novel bystander mechanism of damage in NeuroAIDS and indicate potential new targets for therapeutic interventions, such as DKK1 inhibitors, to reduce the ongoing CNS effects of HIV.
Our findings are in concordance with observations of Séror et al., who reported that ATP rapidly is released from HIV-1 target cells through Panx-1 channels upon interaction with the HIV-1 envelope protein and activation of specific target cell purinergic receptors (including P2Y2), activated proline-rich tyrosine kinase 2 (Pyk2 kinase, an enzyme related to IFN-α, IL-6, IL-10 and IL-12 signaling), and transient plasma membrane depolarization, generating a cascade that involves Panx-1 → ATP → P2Y2 → Pyk2 [181]. They also demonstrated that ATP not only acts as a danger signal but also contributes to viral uptake. Therefore, Panx-1 HCs and purinergic receptors are physically recruited to the site of the infection to facilitate HIV infection [181]. Thus, Panx-1 HCs, ATP, and purinergic receptors accelerate HIV infection and replication (Fig. 3B). Consistent with this conclusion, pharmacological inhibition of the biological activity of the Panx-1 HCs has also been associated with reduced HIV infection and viral replication.
Experiments in human macrophages indicate that HIV infection requires secretion of ATP and activation of purinergic receptors. Our work and the work of others showed that HIV binding to CD4+ T lymphocytes and macrophages also results in activation of Panx-1 HCs, the release of ATP, and activation of specific purinergic receptors [84, 181,182]. Our laboratory demonstrated the participation of P2X1, P2X7, and P2Y1 in HIV replication and showed that P2X1 is necessary for HIV entry into human macrophages. We also demonstrated that interaction of the HIV surface protein gp120 with macrophages stimulates an increase in ATP release and plays a critical role in HIV infection and replication in immune cells by contributing to viral entry and possibly in other steps of the viral lifecycle [84].
ATP in solution is extremely unstable, resulting in ADP, AMP, and adenosine [200,201]. Activation of adenosine receptors (also called P1 receptors) is protective against HIV-tat-induced toxicity in neurons [202,203], suggesting that adenosine may play an important role in preventing HIV-tat neurotoxicity within the CNS. Thus, the opening of HC could also contribute to neuroprotection in some conditions. Additionally, activation of adenosine receptors downregulates the surface expression of CXCR4 and CCR5 on CD4+ T lymphocytes [204], suggesting that adenosine is protective against HIV infection and that blocking Panx-1 HCs can suppress viral replication. Further studies are required to design new therapeutic approaches to reduce and prevent HIV infection and replication in immune and CNS cells.
6. Conclusion
In this review, we have summarized the currently available data about the expression and function of Cx and Panx containing channels, GJs and HCs, in immune cells and their contribution to the immune response to several pathogens. The emerging understanding and discoveries regarding the role of these channels in immune cells and tissues are providing important insight contributing to the development of novel therapeutic targets and approaches to limit the devastating consequences of uncontrolled immune responses involved in multiple pathologies.
Acknowledgments
We would like to thank National NeuroAIDS Tissue Consortium (NNTC) and CNS HIV Anti-retroviral Therapy Effects Research (CHARTER) for providing all human tissue samples described in this review. The National Institute of Mental Health grant, MH096625, and PHRI funding (to E.A.E).
Footnotes
This article is part of a Special Issue entitled: Gap Junction Proteins edited by Jean Claude Herve.
Conflict of interest
None.
References
- 1.Neijssen J, Pang B, Neefjes J. Gap junction-mediated intercellular communication in the immune system. Prog Biophys Mol Biol. 2007;94:207–218. doi: 10.1016/j.pbiomolbio.2007.03.008. [DOI] [PubMed] [Google Scholar]
- 2.Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 2003;83:1359–1400. doi: 10.1152/physrev.00007.2003. [DOI] [PubMed] [Google Scholar]
- 3.Saez JC, Branes MC, Corvalan LA, Eugenin EA, Gonzalez H, Martinez AD, Palisson F. Gap junctions in cells of the immune system: structure, regulation and possible functional roles. Braz J Med Biol Res. 2000;33:447–455. doi: 10.1590/s0100-879x2000000400011. [DOI] [PubMed] [Google Scholar]
- 4.Bennett MV, Zukin RS. Electrical coupling and neuronal synchronization in the mammalian brain. Neuron. 2004;41:495–511. doi: 10.1016/s0896-6273(04)00043-1. [DOI] [PubMed] [Google Scholar]
- 5.Bennett MV, Contreras JE, Bukauskas FF, Saez JC. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci. 2003;26:610–617. doi: 10.1016/j.tins.2003.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bennett MV, Verselis VK. Biophysics of gap junctions. Semin Cell Biol. 1992;3:29–47. doi: 10.1016/s1043-4682(10)80006-6. [DOI] [PubMed] [Google Scholar]
- 7.Saez JC, Contreras JE, Bukauskas FF, Retamal MA, Bennett MV. Gap junction hemichannels in astrocytes of the CNS. Acta Physiol Scand. 2003;179:9–22. doi: 10.1046/j.1365-201X.2003.01196.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Harris AL. Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys. 2001;34:325–472. doi: 10.1017/s0033583501003705. [DOI] [PubMed] [Google Scholar]
- 9.Harris AL. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol. 2007;94:120–143. doi: 10.1016/j.pbiomolbio.2007.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Baranova A, Ivanov D, Petrash N, Pestova A, Skoblov M, Kelmanson I, Shagin D, Nazarenko S, Geraymovych E, Litvin O, Tiunova A, Born TL, Usman N, Staroverov D, Lukyanov S, Panchin Y. The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics. 2004;83:706–716. doi: 10.1016/j.ygeno.2003.09.025. [DOI] [PubMed] [Google Scholar]
- 11.Penuela S, Bhalla R, Gong XQ, Cowan KN, Celetti SJ, Cowan BJ, Bai D, Shao Q, Laird DW. Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J Cell Sci. 2007;120:3772–3783. doi: 10.1242/jcs.009514. [DOI] [PubMed] [Google Scholar]
- 12.Boassa D, Ambrosi C, Qiu F, Dahl G, Gaietta G, Sosinsky G. Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J Biol Chem. 2007;282:31733–31743. doi: 10.1074/jbc.M702422200. [DOI] [PubMed] [Google Scholar]
- 13.Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. 2001;15:10–12. doi: 10.1096/fj.00-0566fje. [DOI] [PubMed] [Google Scholar]
- 14.Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci U S A. 2003;100:13644–13649. doi: 10.1073/pnas.2233464100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bruzzone R, Dermietzel R. Structure and function of gap junctions in the developing brain. Cell Tissue Res. 2006;326:239–248. doi: 10.1007/s00441-006-0287-0. [DOI] [PubMed] [Google Scholar]
- 16.Scemes E, Spray DC, Meda P. Connexins, pannexins, innexins: novel roles of “hemi-channels”. Pflugers Arch. 2009;457:1207–1226. doi: 10.1007/s00424-008-0591-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ray A, Zoidl G, Wahle P, Dermietzel R. Pannexin expression in the cerebellum. Cerebellum. 2006;5:189–192. doi: 10.1080/14734220500530082. [DOI] [PubMed] [Google Scholar]
- 18.Barbe MT, Monyer H, Bruzzone R. Cell-cell communication beyond connexins: the pannexin channels. Physiology. 2006;21:103–114. doi: 10.1152/physiol.00048.2005. [DOI] [PubMed] [Google Scholar]
- 19.MacVicar BA, Thompson RJ. Non-junction functions of pannexin-1 channels. Trends Neurosci. 2010;33:93–102. doi: 10.1016/j.tins.2009.11.007. [DOI] [PubMed] [Google Scholar]
- 20.Prochnow N, Abdulazim A, Kurtenbach S, Wildforster V, Dvoriantchikova G, Hanske J, Petrasch-Parwez E, Shestopalov VI, Dermietzel R, Manahan-Vaughan D, Zoidl G. Pannexin1 stabilizes synaptic plasticity and is needed for learning. PLoS One. 2012;7:e51767. doi: 10.1371/journal.pone.0051767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, Isakson BE, Bayliss DA, Ravichandran KS. Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature. 2010;467:863–867. doi: 10.1038/nature09413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Penuela S, Harland L, Simek J, Laird DW. Pannexin channels and their links to human disease. Biochem J. 2014;461:371–381. doi: 10.1042/BJ20140447. [DOI] [PubMed] [Google Scholar]
- 23.Dahl G, Keane RW. Pannexin: from discovery to bedside in 11+/−4 years? Brain Res. 2012;1487:150–159. doi: 10.1016/j.brainres.2012.04.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Qu Y, Misaghi S, Newton K, Gilmour LL, Louie S, Cupp JE, Dubyak GR, Hackos D, Dixit VM. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J Immunol. 2011;186:6553–6561. doi: 10.4049/jimmunol.1100478. [DOI] [PubMed] [Google Scholar]
- 25.Velasquez S, Eugenin EA. Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases. Front Physiol. 2014;5:96. doi: 10.3389/fphys.2014.00096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kielian T. Glial connexins and gap junctions in CNS inflammation and disease. J Neurochem. 2008;106:1000–1016. doi: 10.1111/j.1471-4159.2008.05405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Eugenin EA. Role of connexin/pannexin containing channels in infectious diseases. FEBS Lett. 2014;588:1389–1395. doi: 10.1016/j.febslet.2014.01.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Oviedo-Orta E, Howard Evans W. Gap junctions and connexin-mediated communication in the immune system. Biochim Biophys Acta. 2004;1662:102–112. doi: 10.1016/j.bbamem.2003.10.021. [DOI] [PubMed] [Google Scholar]
- 29.van Furth R. Current view on the mononuclear phagocyte system. Immunobiology. 1982;161:178–185. doi: 10.1016/S0171-2985(82)80072-7. [DOI] [PubMed] [Google Scholar]
- 30.Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol. 2001;69:11–20. [PubMed] [Google Scholar]
- 31.Davies LC, Taylor PR. Tissue-resident macrophages: then and now. Immunology. 2015;144:541–548. doi: 10.1111/imm.12451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Melnicoff MJ, Horan PK, Breslin EW, Morahan PS. Maintenance of peritoneal macrophages in the steady state. J Leukoc Biol. 1988;44:367–375. doi: 10.1002/jlb.44.5.367. [DOI] [PubMed] [Google Scholar]
- 33.Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia. 1993;7:19–24. doi: 10.1002/glia.440070106. [DOI] [PubMed] [Google Scholar]
- 34.Murphy J, Summer R, Wilson AA, Kotton DN, Fine A. The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol. 2008;38:380–385. doi: 10.1165/rcmb.2007-0224RC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Eugenin EA, Gonzalez HE, Sanchez HA, Branes MC, Saez JC. Inflammatory conditions induce gap junctional communication between rat Kupffer cells both in vivo and in vitro. Cell Immunol. 2007;247:103–110. doi: 10.1016/j.cellimm.2007.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Dobrenis K, Chang HY, Pina-Benabou MH, Woodroffe A, Lee SC, Rozental R, Spray DC, Scemes E. Human and mouse microglia express connexin36, and functional gap junctions are formed between rodent microglia and neurons. J Neurosci Res. 2005;82:306–315. doi: 10.1002/jnr.20650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Eugenin EA, Eckardt D, Theis M, Willecke K, Bennett MV, Saez JC. Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci U S A. 2001;98:4190–4195. doi: 10.1073/pnas.051634298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Eugenin EA, Branes MC, Berman JW, Saez JC. TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J Immunol. 2003;170:1320–1328. doi: 10.4049/jimmunol.170.3.1320. [DOI] [PubMed] [Google Scholar]
- 39.Oviedo-Orta E, Perreau M, Evans WH, Potolicchio I. Control of the proliferation of activated CD4+ T cells by connexins. J Leukoc Biol. 2010;88:79–86. doi: 10.1189/jlb.0909613. [DOI] [PubMed] [Google Scholar]
- 40.Beyer EC, Steinberg TH. Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. J Biol Chem. 1991;266:7971–7974. [PubMed] [Google Scholar]
- 41.Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP. Purinergic signalling in inflammation of the central nervous system. Trends Neurosci. 2009;32:79–87. doi: 10.1016/j.tins.2008.11.003. [DOI] [PubMed] [Google Scholar]
- 42.Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci. 2007;28:465–472. doi: 10.1016/j.tips.2007.07.002. [DOI] [PubMed] [Google Scholar]
- 43.Branes MC, Contreras JE, Saez JC. Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med Sci Monit. 2002;8:BR313–BR323. [PubMed] [Google Scholar]
- 44.Naus CC, Aftab Q, Sin WC. Common mechanisms linking connexin43 to neural progenitor cell migration and glioma invasion. Semin Cell Dev Biol. 2016;50:59–66. doi: 10.1016/j.semcdb.2015.12.008. [DOI] [PubMed] [Google Scholar]
- 45.Machtaler S, Choi K, Dang-Lawson M, Falk L, Pournia F, Naus CC, Matsuuchi L. The role of the gap junction protein connexin43 in B lymphocyte motility and migration. FEBS Lett. 2014;588:1249–1258. doi: 10.1016/j.febslet.2014.01.027. [DOI] [PubMed] [Google Scholar]
- 46.Machtaler S, Dang-Lawson M, Choi K, Jang C, Naus CC, Matsuuchi L. The gap junction protein Cx43 regulates B-lymphocyte spreading and adhesion. J Cell Sci. 2011;124:2611–2621. doi: 10.1242/jcs.089532. [DOI] [PubMed] [Google Scholar]
- 47.Nakase T, Ishikawa T, Miyata H. Protective effects of connexins in atheromatous plaques in patients of carotid artery stenosis. Neuropathology. 2016 doi: 10.1111/neup.12345. [DOI] [PubMed] [Google Scholar]
- 48.Polacek D, Lal R, Volin MV, Davies PF. Gap junctional communication between vascular cells. Induction of connexin43 messenger RNA in macrophage foam cells of atherosclerotic lesions. Am J Pathol. 1993;142:593–606. [PMC free article] [PubMed] [Google Scholar]
- 49.Porvaznik M, MacVittie TJ. Detection of gap junctions between the progeny of a canine macrophage colony-forming cell in vitro. J Cell Biol. 1979;82:555–564. doi: 10.1083/jcb.82.2.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Martin CA, el-Sabban ME, Zhao L, Burakoff R, Homaidan FR. Adhesion and cytosolic dye transfer between macrophages and intestinal epithelial cells. Cell Adhes Commun. 1998;5:83–95. doi: 10.3109/15419069809040283. [DOI] [PubMed] [Google Scholar]
- 51.Afonso A, Lousada S, Silva J, Ellis AE, Silva MT. Neutrophil and macrophage responses to inflammation in the peritoneal cavity of rainbow trout Oncorhynchus mykiss. A light and electron microscopic cytochemical study. Dis Aquat Org. 1998;34:27–37. doi: 10.3354/dao034027. [DOI] [PubMed] [Google Scholar]
- 52.Martin CA, Homaidan FR, Palaia T, Burakoff R, el-Sabban ME. Gap junctional communication between murine macrophages and intestinal epithelial cell lines. Cell Adhes Commun. 1998;5:437–449. doi: 10.3109/15419069809005602. [DOI] [PubMed] [Google Scholar]
- 53.Aasen T. Connexins: junctional and non-junctional modulators of proliferation. Cell Tissue Res. 2015;360:685–699. doi: 10.1007/s00441-014-2078-3. [DOI] [PubMed] [Google Scholar]
- 54.Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES. Connexin 43 breast cancer tumor suppressor: missed connections? Cancer Lett. 2016;374:117–126. doi: 10.1016/j.canlet.2016.02.008. [DOI] [PubMed] [Google Scholar]
- 55.Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39:151–170. doi: 10.1016/0306-4522(90)90229-w. [DOI] [PubMed] [Google Scholar]
- 56.Cepeda C, Chang JW, Owens GC, Huynh MN, Chen JY, Tran C, Vinters HV, Levine MS, Mathern GW. Rasmussen encephalitis, hemichannels associated with microglial activation are linked to cortical pyramidal neuron coupling: a possible mechanism for cellular hyperexcitability. CNS Neurosci Ther. 2015;21:152–163. doi: 10.1111/cns.12352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Eugenin EA, Basilio D, Saez JC, Orellana JA, Raine CS, Bukauskas F, Bennett MV, Berman JW. The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J NeuroImmune Pharmacol. 2012;7:499–518. doi: 10.1007/s11481-012-9352-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Moon Y, Choi SY, Kim K, Kim H, Sun W. Expression of connexin29 and 32 in the penumbra region after traumatic brain injury of mice. Neuroreport. 2010;21:1135–1139. doi: 10.1097/WNR.0b013e32834051c7. [DOI] [PubMed] [Google Scholar]
- 59.Garg S, Md Syed M, Kielian T. Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. J Neurochem. 2005;95:475–483. doi: 10.1111/j.1471-4159.2005.03384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Corvalan LA, Araya R, Branes MC, Saez PJ, Kalergis AM, Tobar JA, Theis M, Willecke K, Saez JC. Injury of skeletal muscle and specific cytokines induce the expression of gap junction channels in mouse dendritic cells. J Cell Physiol. 2007;211:649–660. doi: 10.1002/jcp.20971. [DOI] [PubMed] [Google Scholar]
- 61.Handel A, Yates A, Pilyugin SS, Antia R. Gap junction-mediated antigen transport in immune responses. Trends Immunol. 2007;28:463–466. doi: 10.1016/j.it.2007.08.006. [DOI] [PubMed] [Google Scholar]
- 62.Matsue H, Yao J, Matsue K, Nagasaka A, Sugiyama H, Aoki R, Kitamura M, Shimada S. Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs. J Immunol. 2006;176:181–190. doi: 10.4049/jimmunol.176.1.181. [DOI] [PubMed] [Google Scholar]
- 63.Mendoza-Naranjo A, Saez PJ, Johansson CC, Ramirez M, Mandakovic D, Pereda C, Lopez MN, Kiessling R, Saez JC, Salazar-Onfray F. Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells. J Immunol. 2007;178:6949–6957. doi: 10.4049/jimmunol.178.11.6949. [DOI] [PubMed] [Google Scholar]
- 64.Neijssen J, Herberts C, Drijfhout JW, Reits E, Janssen L, Neefjes J. Cross-presentation by intercellular peptide transfer through gap junctions. Nature. 2005;434:83–88. doi: 10.1038/nature03290. [DOI] [PubMed] [Google Scholar]
- 65.Pang B, Neijssen J, Qiao X, Janssen L, Janssen H, Lippuner C, Neefjes J. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis. J Immunol. 2009;183:1083–1090. doi: 10.4049/jimmunol.0900861. [DOI] [PubMed] [Google Scholar]
- 66.Mazzini E, Massimiliano L, Penna G, Rescigno M. Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1(+) macrophages to CD103(+) dendritic cells. Immunity. 2014;40:248–261. doi: 10.1016/j.immuni.2013.12.012. [DOI] [PubMed] [Google Scholar]
- 67.Law KM, Satija N, Esposito AM, Chen BK. Cell-to-cell spread of HIV and viral pathogenesis. Adv Virus Res. 2016;95:43–85. doi: 10.1016/bs.aivir.2016.03.001. [DOI] [PubMed] [Google Scholar]
- 68.Gross C, Thoma-Kress AK. Molecular mechanisms of HTLV-1 cell-to-cell transmission. Viruses. 2016;8:74. doi: 10.3390/v8030074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Contreras JE, Saez JC, Bukauskas FF, Bennett MV. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc Natl Acad Sci U S A. 2003;100:11388–11393. doi: 10.1073/pnas.1434298100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Quist AP, Rhee SK, Lin H, Lal R. Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol. 2000;148:1063–1074. doi: 10.1083/jcb.148.5.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Stout CE, Costantin JL, Naus CC, Charles AC. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem. 2002;277:10482–10488. doi: 10.1074/jbc.M109902200. [DOI] [PubMed] [Google Scholar]
- 72.Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem. 2002;277:8648–8657. doi: 10.1074/jbc.M108625200. [DOI] [PubMed] [Google Scholar]
- 73.Contreras JE, Sanchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, Bukauskas FF, Bennett MV, Saez JC. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci U S A. 2002;99:495–500. doi: 10.1073/pnas.012589799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Csoka B, Nemeth ZH, Toro G, Idzko M, Zech A, Koscso B, Spolarics Z, Antonioli L, Cseri K, Erdelyi K, Pacher P, Hasko G. Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. FASEB J. 2015;29:3626–3637. doi: 10.1096/fj.15-272450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.De Vuyst E, Decrock E, Cabooter L, Dubyak GR, Naus CC, Evans WH, Leybaert L. Intracellular calcium changes trigger connexin 32 hemichannel opening. EMBO J. 2006;25:34–44. doi: 10.1038/sj.emboj.7600908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Kirischuk S, Scherer J, Kettenmann H, Verkhratsky A. Activation of P2-purinoreceptors triggered Ca2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J Physiol. 1995;483(Pt 1):41–57. doi: 10.1113/jphysiol.1995.sp020566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.James G, Butt AM. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium. 2001;30:251–259. doi: 10.1054/ceca.2001.0232. [DOI] [PubMed] [Google Scholar]
- 78.Gomes P, Srinivas SP, Van Driessche W, Vereecke J, Himpens B. ATP release through connexin hemichannels in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2005;46:1208–1218. doi: 10.1167/iovs.04-1181. [DOI] [PubMed] [Google Scholar]
- 79.Romanello M, Pani B, Bicego M, D'Andrea P. Mechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun. 2001;289:1275–1281. doi: 10.1006/bbrc.2001.6124. [DOI] [PubMed] [Google Scholar]
- 80.Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med. 2006;12:950–954. doi: 10.1038/nm1441. [DOI] [PubMed] [Google Scholar]
- 81.Orellana JA, Saez JC, Bennett MV, Berman JW, Morgello S, Eugenin EA. HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. J Neurochem. 2014;128:752–763. doi: 10.1111/jnc.12492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Penuela S, Gehi R, Laird DW. The biochemistry and function of pannexin channels. Biochim Biophys Acta. 2013;1828:15–22. doi: 10.1016/j.bbamem.2012.01.017. [DOI] [PubMed] [Google Scholar]
- 83.Bao BA, Lai CP, Naus CC, Morgan JR. Pannexin1 drives multicellular aggregate compaction via a signaling cascade that remodels the actin cytoskeleton. J Biol Chem. 2012;287:8407–8416. doi: 10.1074/jbc.M111.306522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Hazleton JE, Berman JW, Eugenin EA. Purinergic receptors are required for HIV-1 infection of primary human macrophages. J Immunol. 2012;188:4488–4495. doi: 10.4049/jimmunol.1102482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 2011;59:1933–1945. doi: 10.1002/glia.21235. [DOI] [PubMed] [Google Scholar]
- 86.Orellana JA, Busso D, Ramirez G, Campos M, Rigotti A, Eugenin J, von Bernhardi R. Prenatal nicotine exposure enhances Cx43 and Panx1 unopposed channel activity in brain cells of adult offspring mice fed a high-fat/cholesterol diet. Front Cell Neurosci. 2014;8:403. doi: 10.3389/fncel.2014.00403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Rigato C, Swinnen N, Buckinx R, Couillin I, Mangin JM, Rigo JM, Legendre P, Le Corronc H. Microglia proliferation is controlled by P2X7 receptors in a Pannexin-1-independent manner during early embryonic spinal cord invasion. J Neurosci. 2012;32:11559–11573. doi: 10.1523/JNEUROSCI.1042-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Shestopalov VI, Slepak VZ. Molecular pathways of pannexin1-mediated neurotoxicity. Front Physiol. 2014;5:23. doi: 10.3389/fphys.2014.00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MV, Naus CC, Giaume C, Saez JC. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem. 2011;118:826–840. doi: 10.1111/j.1471-4159.2011.07210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Orellana JA, Shoji KF, Abudara V, Ezan P, Amigou E, Saez PJ, Jiang JX, Naus CC, Saez JC, Giaume C. Amyloid beta-induced death in neurons involves glial and neuronal hemichannels. J Neurosci. 2011;31:4962–4977. doi: 10.1523/JNEUROSCI.6417-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Saez PJ, Shoji KF, Retamal MA, Harcha PA, Ramirez G, Jiang JX, von Bernhardi R, Saez JC. ATP is required and advances cytokine-induced gap junction formation in microglia in vitro. Mediat Inflamm. 2013;2013:216402. doi: 10.1155/2013/216402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Saez PJ, Shoji KF, Aguirre A, Saez JC. Regulation of hemichannels and gap junction channels by cytokines in antigen-presenting cells. Mediat Inflamm. 2014;2014:742734. doi: 10.1155/2014/742734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Saez JC, Cisterna BA, Vargas A, Cardozo CP. Regulation of pannexin and connexin channels and their functional role in skeletal muscles. Cell Mol Life Sci. 2015;72:2929–2935. doi: 10.1007/s00018-015-1968-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Burnstock G, Boeynaems JM. Purinergic signalling and immune cells. Purinergic Signal. 2014;10:529–564. doi: 10.1007/s11302-014-9427-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Yu F, Yan H, Nie W, Zhu J. Connexin43 knockdown in bone marrowderived dendritic cells by small interfering RNA leads to a diminished T-cell stimulation. Mol Med Rep. 2016;13:895–900. doi: 10.3892/mmr.2015.4593. [DOI] [PubMed] [Google Scholar]
- 96.Watanabe M, Masaki K, Yamasaki R, Kawanokuchi J, Takeuchi H, Matsushita T, Suzumura A, Kira JI. Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation. Sci Rep. 2016;6:38387. doi: 10.1038/srep38387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjoro T, Pfeifer-Ohlsson S, Watt R, Funderud S, Godal T, et al. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol. 1987;131:426–433. doi: 10.1002/jcp.1041310315. [DOI] [PubMed] [Google Scholar]
- 98.Kambayashi T, Wallin RP, Ljunggren HG. cAMP-elevating agents suppress dendritic cell function. J Leukoc Biol. 2001;70:903–910. [PubMed] [Google Scholar]
- 99.Aandahl EM, Moretto WJ, Haslett PA, Vang T, Bryn T, Tasken K, Nixon DF. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J Immunol. 2002;169:802–808. doi: 10.4049/jimmunol.169.2.802. [DOI] [PubMed] [Google Scholar]
- 100.Kaneko T, Alvarez R, Ueki IF, Nadel JA. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell Signal. 1995;7:527–534. doi: 10.1016/0898-6568(95)00023-i. [DOI] [PubMed] [Google Scholar]
- 101.Mikami N, Watanabe K, Hashimoto N, Miyagi Y, Sueda K, Fukada S, Yamamoto H, Tsujikawa K. Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions. Int Immunol. 2012;24:681–691. doi: 10.1093/intimm/dxs075. [DOI] [PubMed] [Google Scholar]
- 102.Datta SK, Sabet M, Nguyen KP, Valdez PA, Gonzalez-Navajas JM, Islam S, Mihajlov I, Fierer J, Insel PA, Webster NJ, Guiney DG, Raz E. Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A. 2010;107:10638–10643. doi: 10.1073/pnas.1002348107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Rueda CM, Jackson CM, Chougnet CA. Regulatory T-cell-mediated suppression of conventional T-cells and dendritic cells by different cAMP intracellular pathways. Front Immunol. 2016;7:216. doi: 10.3389/fimmu.2016.00216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med. 2007;204:1303–1310. doi: 10.1084/jem.20062129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Wehbi VL, Tasken K. Molecular mechanisms for cAMP-mediated immunoregulation in T cells - role of anchored protein kinase a signaling units. Front Immunol. 2016;7:222. doi: 10.3389/fimmu.2016.00222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Benlalam H, Carre T, Jalil A, Noman Z, Caillou B, Vielh P, Tittarelli A, Robert C, Chouaib S. Regulation of gap junctions in melanoma and their impact on Melan-A/ MART-1-specific CD8(+) T lymphocyte emergence. J Mol Med (Berl) 2013;91:1207–1220. doi: 10.1007/s00109-013-1058-5. [DOI] [PubMed] [Google Scholar]
- 107.Mendoza-Naranjo A, Bouma G, Pereda C, Ramirez M, Webb KF, Tittarelli A, Lopez MN, Kalergis AM, Thrasher AJ, Becker DL, Salazar-Onfray F. Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation. J Immunol. 2011;187:3121–3132. doi: 10.4049/jimmunol.1100378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Glass AM, Snyder EG, Taffet SM. Connexins and pannexins in the immune system and lymphatic organs. Cell Mol Life Sci. 2015;72:2899–2910. doi: 10.1007/s00018-015-1966-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Oviedo-Orta E, Evans WH. Gap junctions and connexins: potential contributors to the immunological synapse. J Leukoc Biol. 2002;72:636–642. [PubMed] [Google Scholar]
- 110.Tittarelli A, Mendoza-Naranjo A, Farias M, Guerrero I, Ihara F, Wennerberg E, Riquelme S, Gleisner A, Kalergis A, Lundqvist A, Lopez MN, Chambers BJ, Salazar-Onfray F. Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity. J Immunol. 2014;192:1313–1319. doi: 10.4049/jimmunol.1301297. [DOI] [PubMed] [Google Scholar]
- 111.Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L, Arienti F, Belardelli F, Parmiani G, Rivoltini L. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol. 2004;172:5363–5370. doi: 10.4049/jimmunol.172.9.5363. [DOI] [PubMed] [Google Scholar]
- 112.Manohar M, Hirsh MI, Chen Y, Woehrle T, Karande AA, Junger WG. ATP release and autocrine signaling through P2X4 receptors regulate gammadelta T cell activation. J Leukoc Biol. 2012;92:787–794. doi: 10.1189/jlb.0312121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal. 2008;1:ra6. doi: 10.1126/scisignal.1160583. [DOI] [PubMed] [Google Scholar]
- 114.Al-Ghadban S, Kaissi S, Homaidan FR, Naim HY, El-Sabban ME. Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel disease. Sci Rep-Uk. 2016;6:29783. doi: 10.1038/srep29783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Diezmos EF, Bertrand PP, Liu L. Purinergic signaling in gut inflammation: the role of connexins and pannexins. Front Neurosci. 2016;10:311. doi: 10.3389/fnins.2016.00311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Nemeth L, Maddur S, Puri P. Immunolocalization of the gap junction protein Connexin43 in the interstitial cells of Cajal in the normal and Hirschsprung's disease bowel. J Pediatr Surg. 2000;35:823–828. doi: 10.1053/jpsu.2000.6851. [DOI] [PubMed] [Google Scholar]
- 117.Jara PI, Boric MP, Saez JC. Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc Natl Acad Sci U S A. 1995;92:7011–7015. doi: 10.1073/pnas.92.15.7011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Vliagoftis H, Ebeling C, Ilarraza R, Mahmudi-Azer S, Abel M, Adamko D, Befus AD, Moqbel R. Connexin 43 expression on peripheral blood eosinophils: role of gap junctions in transendothelial migration. Biomed Res Int. 2014;2014:803257. doi: 10.1155/2014/803257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Oviedo-Orta E, Errington RJ, Evans WH. Gap junction intercellular communication during lymphocyte transendothelial migration. Cell Biol Int. 2002;26:253–263. doi: 10.1006/cbir.2001.0840. [DOI] [PubMed] [Google Scholar]
- 120.Chen Y, Bao Y, Zhang J, Woehrle T, Sumi Y, Ledderose S, Li X, Ledderose C, Junger WG. Inhibition of neutrophils by hypertonic saline involves Pannexin-1, CD39, CD73, and other ectonucleotidases. Shock. 2015;44:221–227. doi: 10.1097/SHK.0000000000000402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today. 1992;13:501–507. doi: 10.1016/0167-5699(92)90026-4. [DOI] [PubMed] [Google Scholar]
- 122.Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev. 2001;179:163–172. doi: 10.1034/j.1600-065x.2001.790116.x. [DOI] [PubMed] [Google Scholar]
- 123.Vliagoftis H, Hutson AM, Mahmudi-Azer S, Kim H, Rumsaeng V, Oh CK, Moqbel R, Metcalfe DD. Mast cells express connexins on their cytoplasmic membrane. J Allergy Clin Immunol. 1999;103:656–662. doi: 10.1016/s0091-6749(99)70239-3. [DOI] [PubMed] [Google Scholar]
- 124.Pistorio AL, Ehrlich HP. Modulatory effects of connexin-43 expression on gap junction intercellular communications with mast cells and fibroblasts. J Cell Biochem. 2011;112:1441–1449. doi: 10.1002/jcb.23061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Aguirre A, Maturana CJ, Harcha PA, Saez JC. Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediat Inflamm. 2013;2013:893521. doi: 10.1155/2013/893521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Diezmos EF, Sandow SL, Perera DS, King DW, Bertrand PP, Liu L. Pannexin-2 is expressed in the human colon with extensive localization in the enteric nervous system. Neurogastroenterol Motil. 2015;27:672–683. doi: 10.1111/nmo.12541. [DOI] [PubMed] [Google Scholar]
- 127.Becker DL, Thrasivoulou C, Phillips AR. Connexins in wound healing; perspectives in diabetic patients. Biochim Biophys Acta. 2012;1818:2068–2075. doi: 10.1016/j.bbamem.2011.11.017. [DOI] [PubMed] [Google Scholar]
- 128.Willebrords J, Crespo Yanguas S, Maes M, Decrock E, Wang N, Leybaert L, Kwak BR, Green CR, Cogliati B, Vinken M. Connexins and their channels in inflammation. Crit Rev Biochem Mol Biol. 2016:1–27. doi: 10.1080/10409238.2016.1204980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest. 2015;125:3347–3355. doi: 10.1172/JCI80007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Waisman A, Liblau RS, Becher B. Innate and adaptive immune responses in the CNS. Lancet Neurol. 2015;14:945–955. doi: 10.1016/S1474-4422(15)00141-6. [DOI] [PubMed] [Google Scholar]
- 131.Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–435. doi: 10.1038/nature07201. [DOI] [PubMed] [Google Scholar]
- 132.Frimmel K, Sotnikova R, Navarova J, Bernatova I, KriZak J, Haviarova Z, Kura B, Slezak J, Okruhlicova L. Omega-3 fatty acids reduce lipopolysaccharide-induced abnormalities in expression of connexin-40 in aorta of hereditary hypertriglyceridemic rats. Physiol Res. 2016;65(Suppl 1):S65–S76. doi: 10.33549/physiolres.933401. [DOI] [PubMed] [Google Scholar]
- 133.Adesse D, Garzoni LR, Huang H, Tanowitz HB, de Nazareth Meirelles M, Spray DC. Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect. 2008;10:21–28. doi: 10.1016/j.micinf.2007.09.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine. 1999;11:216–224. doi: 10.1006/cyto.1998.0422. [DOI] [PubMed] [Google Scholar]
- 135.Park H, Ku SH, Hong J, Kim D, Choi BR, Pak HN, Lee MH, Mok H, Jeong JH, Choi D, Kim SH, Joung B. RAGE siRNA-mediated gene silencing provides cardioprotection against ventricular arrhythmias in acute ischemia and reperfusion. J Control Release. 2015;217:315–326. doi: 10.1016/j.jconrel.2015.09.006. [DOI] [PubMed] [Google Scholar]
- 136.Kant S, Holthofer B, Magin TM, Krusche CA, Leube RE. Desmoglein 2-dependent arrhythmogenic cardiomyopathy is caused by a loss of adhesive function. Circ Cardiovasc Genet. 2015;8:553–563. doi: 10.1161/CIRCGENETICS.114.000974. [DOI] [PubMed] [Google Scholar]
- 137.Zhang J, Yang GM, Zhu Y, Peng XY, Li T, Liu LM. Role of connexin 43 in vascular hyperpermeability and relationship to Rock1-MLC20 pathway in septic rats. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1323–L1332. doi: 10.1152/ajplung.00016.2015. [DOI] [PubMed] [Google Scholar]
- 138.Maes M, McGill MR, da Silva TC, Abels C, Lebofsky M, Maria Monteiro de Araujo C, Tiburcio T, Veloso Alves Pereira I, Willebrords J, Crespo Yanguas S, Farhood A, Beschin A, Van Ginderachter JA, Zaidan Dagli ML, Jaeschke H, Cogliati B, Vinken M. Involvement of connexin43 in acetaminophen-induced liver injury. Biochim Biophys Acta. 2016;1862:1111–1121. doi: 10.1016/j.bbadis.2016.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Sagawa H, Naiki-Ito A, Kato H, Naiki T, Yamashita Y, Suzuki S, Sato S, Shiomi K, Kato A, Kuno T, Matsuo Y, Kimura M, Takeyama H, Takahashi S. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats. Carcinogenesis. 2015;36:1539–1549. doi: 10.1093/carcin/bgv143. [DOI] [PubMed] [Google Scholar]
- 140.Zhou JJ, Cheng C, Qiu Z, Zhou WH, Cheng GQ. Decreased connexin 43 in astrocytes inhibits the neuroinflammatory reaction in an acute mouse model of neonatal sepsis. Neurosci Bull. 2015;31:763–768. doi: 10.1007/s12264-015-1561-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Sharma R, Fischer MT, Bauer J, Felts PA, Smith KJ, Misu T, Fujihara K, Bradl M, Lassmann H. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol. 2010;120:223–236. doi: 10.1007/s00401-010-0704-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Simon AM, McWhorter AR, Chen H, Jackson CL, Ouellette Y. Decreased intercellular communication and connexin expression in mouse aortic endothelium during lipopolysaccharide-induced inflammation. J Vasc Res. 2004;41:323–333. doi: 10.1159/000079614. [DOI] [PubMed] [Google Scholar]
- 143.Freund-Michel V, Muller B, Marthan R, Savineau JP, Guibert C. Expression and role of connexin-based gap junctions in pulmonary inflammatory diseases. Pharmacol Ther. 2016;164:105–119. doi: 10.1016/j.pharmthera.2016.04.004. [DOI] [PubMed] [Google Scholar]
- 144.Duffy HS, John GR, Lee SC, Brosnan CF, Spray DC. Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1beta in primary human fetal astrocytes. J Neurosci. 2000;20:RC114. doi: 10.1523/JNEUROSCI.20-23-j0004.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Temme A, Traub O, Willecke K. Downregulation of connexin32 protein and gap-junctional intercellular communication by cytokine-mediated acute-phase response in immortalized mouse hepatocytes. Cell Tissue Res. 1998;294:345–350. doi: 10.1007/s004410051184. [DOI] [PubMed] [Google Scholar]
- 146.Fischer R, Reinehr R, Lu TP, Schonicke A, Warskulat U, Dienes HP, Haussinger D. Intercellular communication via gap junctions in activated rat hepatic stellate cells. Gastroenterology. 2005;128:433–448. doi: 10.1053/j.gastro.2004.11.065. [DOI] [PubMed] [Google Scholar]
- 147.Gonzalez HE, Eugenin EA, Garces G, Solis N, Pizarro M, Accatino L, Saez JC. Regulation of hepatic connexins in cholestasis: possible involvement of Kupffer cells and inflammatory mediators. Am J Physiol Gastrointest Liver Physiol. 2002;282:G991–G1001. doi: 10.1152/ajpgi.00298.2001. [DOI] [PubMed] [Google Scholar]
- 148.Frimmel K, Vlkovicova J, Sotnikova R, Navarova J, Bernatova I, Okruhlicova L. The effect of omega-3 fatty acids on expression of connexin-40 in Wistar rat aorta after lipopolysaccharide administration. J Physiol Pharmacol. 2014;65:83–94. [PubMed] [Google Scholar]
- 149.Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006;112:358–404. doi: 10.1016/j.pharmthera.2005.04.013. [DOI] [PubMed] [Google Scholar]
- 150.Velasquez S, Malik S, Lutz SE, Scemes E, Eugenin EA. Pannexin1 channels are required for chemokine-mediated migration of CD4+ T lymphocytes: role in inflammation and experimental autoimmune encephalomyelitis. J Immunol. 2016;196:4338–4347. doi: 10.4049/jimmunol.1502440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Diezmos EF, Sandow SL, Markus I, Shevy Perera D, Lubowski DZ, King DW, Bertrand PP, Liu L. Expression and localization of pannexin-1 hemichannels in human colon in health and disease. Neurogastroenterol Motil. 2013;25:e395–e405. doi: 10.1111/nmo.12130. [DOI] [PubMed] [Google Scholar]
- 152.Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA, Muruve DA, McKay DM, Beck PL, Mawe GM, Thompson RJ, Sharkey KA. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med. 2012;18:600–604. doi: 10.1038/nm.2679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Brown IA, McClain JL, Watson RE, Patel BA, Gulbransen BD. Enteric glia mediate neuron death in colitis through purinergic pathways that require connexin-43 and nitric oxide. Cell Mol Gastroenterol Hepatol. 2016;2:77–91. doi: 10.1016/j.jcmgh.2015.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Alves LA, Coutinho-Silva R, Persechini PM, Spray DC, Savino W, Campos de Carvalho AC. Are there functional gap junctions or junctional hemichannels in macrophages? Blood. 1996;88:328–334. [PubMed] [Google Scholar]
- 155.Adamson SE, Leitinger N. The role of pannexin1 in the induction and resolution of inflammation. FEBS Lett. 2014;588:1416–1422. doi: 10.1016/j.febslet.2014.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Li H, Liu TF, Lazrak A, Peracchia C, Goldberg GS, Lampe PD, Johnson RG. Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J Cell Biol. 1996;134:1019–1030. doi: 10.1083/jcb.134.4.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN. Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem. 1999;274:236–240. doi: 10.1074/jbc.274.1.236. [DOI] [PubMed] [Google Scholar]
- 158.Ali SR, Timmer AM, Bilgrami S, Park EJ, Eckmann L, Nizet V, Karin M. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity. 2011;35:34–44. doi: 10.1016/j.immuni.2011.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Dobrowolski R, Sasse P, Schrickel JW, Watkins M, Kim JS, Rackauskas M, Troatz C, Ghanem A, Tiemann K, Degen J, Bukauskas FF, Civitelli R, Lewalter T, Fleischmann BK, Willecke K. The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet. 2008;17:539–554. doi: 10.1093/hmg/ddm329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, Weissmuller T, Boengler K, Schulz R, Robson SC, Colgan SP. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res. 2006;99:1100–1108. doi: 10.1161/01.RES.0000250174.31269.70. [DOI] [PubMed] [Google Scholar]
- 161.Faigle M, Seessle J, Zug S, El Kasmi KC, Eltzschig HK. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One. 2008;3:e2801. doi: 10.1371/journal.pone.0002801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Goldberg GS, Moreno AP, Lampe PD. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J Biol Chem. 2002;277:36725–36730. doi: 10.1074/jbc.M109797200. [DOI] [PubMed] [Google Scholar]
- 163.Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, Nedergaard M. Connexin 43 hemichannels are permeable to ATP. J Neurosci. 2008;28:4702–4711. doi: 10.1523/JNEUROSCI.5048-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Alvarez A, Lagos-Cabre R, Kong M, Cardenas A, Burgos-Bravo F, Schneider P, Quest AF, Leyton L. Integrin-mediated transactivation of P2X7R via hemichannel-dependent ATP release stimulates astrocyte migration. Biochim Biophys Acta. 2016;1863:2175–2188. doi: 10.1016/j.bbamcr.2016.05.018. [DOI] [PubMed] [Google Scholar]
- 165.Chisari M, Scuderi A, Ciranna L, Volsi GL, Licata F, Sortino MA. Purinergic P2Y1 receptors control rapid expression of plasma membrane processes in hippocampal astrocytes. Mol Neurobiol. 2016 doi: 10.1007/s12035-016-9955-6. [DOI] [PubMed] [Google Scholar]
- 166.Yi C, Mei X, Ezan P, Mato S, Matias I, Giaume C, Koulakoff A. Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease. Cell Death Differ. 2016;23:1691–1701. doi: 10.1038/cdd.2016.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Iglesias R, Dahl G, Qiu F, Spray DC, Scemes E. Pannexin 1: the molecular substrate of astrocyte “hemichannels”. J Neurosci. 2009;29:7092–7097. doi: 10.1523/JNEUROSCI.6062-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Huang C, Han X, Li X, Lam E, Peng W, Lou N, Torres A, Yang M, Garre JM, Tian GF, Bennett MV, Nedergaard M, Takano T. Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J Neurosci. 2012;32:3333–3338. doi: 10.1523/JNEUROSCI.1216-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Mohammad M, Habib HS. Pannexin channels: the emerging therapeutic targets. Curr Drug Targets. 2014;15:272–280. doi: 10.2174/13894501113146660217. [DOI] [PubMed] [Google Scholar]
- 170.Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and in-terleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 2006;25:5071–5082. doi: 10.1038/sj.emboj.7601378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Locovei S, Scemes E, Qiu F, Spray DC, Dahl G. Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 2007;581:483–488. doi: 10.1016/j.febslet.2006.12.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Said-Sadier N, Ojcius DM. Alarmins, inflammasomes and immunity. Biom J. 2012;35:437–449. doi: 10.4103/2319-4170.104408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Hung SC, Choi CH, Said-Sadier N, Johnson L, Atanasova KR, Sellami H, Yilmaz O, Ojcius DM. P2X4 assembles with P2X7 and pannexin-1 in gingival epithelial cells and modulates ATP-induced reactive oxygen species production and inflammasome activation. PLoS One. 2013;8:e70210. doi: 10.1371/journal.pone.0070210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Draganov D, Gopalakrishna-Pillai S, Chen YR, Zuckerman N, Moeller S, Wang C, Ann D, Lee PP. Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep-Uk. 2015;5:16222. doi: 10.1038/srep16222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Burnstock G, Verkhratsky A. Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis. 2010;1:e9. doi: 10.1038/cddis.2009.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Dixon CJ, Bowler WB, Fleetwood P, Ginty AF, Gallagher JA, Carron JA. Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br J Cancer. 1997;75:34–39. doi: 10.1038/bjc.1997.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci. 2006;27:211–217. doi: 10.1016/j.tips.2006.02.004. [DOI] [PubMed] [Google Scholar]
- 178.Antinori A, Perno CF, Giancola ML, Forbici F, Ippolito G, Hoetelmans RM, Piscitelli SC. Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma. Clin Infect Dis. 2005;41:1787–1793. doi: 10.1086/498310. [DOI] [PubMed] [Google Scholar]
- 179.Eisfeld C, Reichelt D, Evers S, Husstedt I. CSF penetration by antiretroviral drugs. CNS Drugs. 2013;27:31–55. doi: 10.1007/s40263-012-0018-x. [DOI] [PubMed] [Google Scholar]
- 180.Daniyal M, Akram M, Hamid A, Nawaz A, Usmanghani K, Ahmed S, Hameed L. Review: comprehensive review on treatment of HIV. Pak J Pharm Sci. 2016;29:1331–1338. [PubMed] [Google Scholar]
- 181.Seror C, Melki MT, Subra F, Raza SQ, Bras M, Saidi H, Nardacci R, Voisin L, Paoletti A, Law F, Martins I, Amendola A, Abdul-Sater AA, Ciccosanti F, Delelis O, Niedergang F, Thierry S, Said-Sadier N, Lamaze C, Metivier D, Estaquier J, Fimia GM, Falasca L, Casetti R, Modjtahedi N, Kanellopoulos J, Mouscadet JF, Ojcius DM, Piacentini M, Gougeon ML, Kroemer G, Perfettini JL. Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med. 2011;208:1823–1834. doi: 10.1084/jem.20101805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Orellana JA, Velasquez S, Williams DW, Saez JC, Berman JW, Eugenin EA. Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes. J Leukoc Biol. 2013;94:399–407. doi: 10.1189/jlb.0512249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Eugenin EA, King JE, Hazleton JE, Major EO, Bennett MV, Zukin RS, Berman JW. Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity. Neurotox Res. 2011;19:138–148. doi: 10.1007/s12640-010-9150-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Malik S, Eugenin EA. Mechanisms of HIV neuropathogenesis: role of cellular communication systems. Curr HIV Res. 2016;14:400–411. doi: 10.2174/1570162x14666160324124558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neuro-Oncol. 2004;10:350–357. doi: 10.1080/13550280490521078. [DOI] [PubMed] [Google Scholar]
- 186.Gelman BB. Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV/AIDS Rep. 2015;12:272–279. doi: 10.1007/s11904-015-0266-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Hellmuth J, Milanini B, Valcour V. Interactions between ageing and NeuroAIDS. Curr Opin HIV AIDS. 2014;9:527–532. doi: 10.1097/COH.0000000000000104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19:152–168. doi: 10.1007/s11065-009-9102-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Eugenin EA, Berman JW. Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism. J Neurochem. 2013;127:644–651. doi: 10.1111/jnc.12443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Eugenin EA, Berman JW. Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci Off J Soc Neurosci. 2007;27:12844–12850. doi: 10.1523/JNEUROSCI.4154-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Eugenin EA, Clements JE, Zink MC, Berman JW. Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci. 2011;31:9456–9465. doi: 10.1523/JNEUROSCI.1460-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 192.Girouard H, Bonev AD, Hannah RM, Meredith A, Aldrich RW, Nelson MT. Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction. Proc Natl Acad Sci U S A. 2010;107:3811–3816. doi: 10.1073/pnas.0914722107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193.Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem. 2003;85:1299–1311. doi: 10.1046/j.1471-4159.2003.01775.x. [DOI] [PubMed] [Google Scholar]
- 194.Berman JW, Carvallo L, Buckner CM, Luers A, Prevedel L, Bennett MV, Eugenin EA. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. J Neuroinflammation. 2016;13:54. doi: 10.1186/s12974-016-0510-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 195.Eugenin EA, Dyer G, Calderon TM, Berman JW. HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS. Glia. 2005;49:501–510. doi: 10.1002/glia.20137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/ monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci. 2006;26:1098–1106. doi: 10.1523/JNEUROSCI.3863-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197.Eugenin EA, Berman JW. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods. 2003;29:351–361. doi: 10.1016/s1046-2023(02)00359-6. [DOI] [PubMed] [Google Scholar]
- 198.Melikyan GB. Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein. Curr Top Membr. 2011;68:81–106. doi: 10.1016/B978-0-12-385891-7.00004-0. [DOI] [PubMed] [Google Scholar]
- 199.Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004;25:75–84. doi: 10.1016/j.it.2003.12.005. [DOI] [PubMed] [Google Scholar]
- 200.Li A, Banerjee J, Leung CT, Peterson-Yantorno K, Stamer WD, Civan MM. Mechanisms of ATP release, the enabling step in purinergic dynamics. Cell Physiol Biochem. 2011;28:1135–1144. doi: 10.1159/000335865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Dombrowski KE, Brewer KA, Maleckar JR, Kirley TL, Thomas JW, Kapp JA. Identification and partial characterization of ectoATPase expressed by immortalized B lymphocytes. Arch Biochem Biophys. 1997;340:10–18. doi: 10.1006/abbi.1997.9904. [DOI] [PubMed] [Google Scholar]
- 202.Pingle SC, Jajoo S, Mukherjea D, Sniderhan LF, Jhaveri KA, Marcuzzi A, Rybak LP, Maggirwar SB, Ramkumar V. Activation of the adenosine A1 receptor inhibits HIV-1 tat-induced apoptosis by reducing nuclear factor-kappaB activation and inducible nitric-oxide synthase. Mol Pharmacol. 2007;72:856–867. doi: 10.1124/mol.106.031427. [DOI] [PubMed] [Google Scholar]
- 203.Fotheringham J, Mayne M, Holden C, Nath A, Geiger JD. Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Virology. 2004;327:186–195. doi: 10.1016/j.virol.2004.07.007. [DOI] [PubMed] [Google Scholar]
- 204.By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Fenouillet E, Guieu R, Ruf J. Mono-clonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells. Hum Immunol. 2010;71:1073–1076. doi: 10.1016/j.humimm.2010.08.010. [DOI] [PubMed] [Google Scholar]